Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SKIN NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06977360
What this trial is testing

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 40
Large-scale testing (Phase 3)UnknownNCT05783882
What this trial is testing

Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Biocad 114
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Not applicableUnknownNCT03667560
What this trial is testing

Dermacell ADM Without Basement Membrane

Who this might be right for
Breast Cancer
University of Virginia 120
Not applicableStudy completedNCT02878382
What this trial is testing

Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT

Who this might be right for
Actinic Keratosis
University of Sao Paulo 20
Not applicableLooking for participantsNCT07250204
What this trial is testing

A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.

Who this might be right for
Breast CancerNipple Discharge
Hubei Cancer Hospital 60
Not applicableUnknownNCT00701584
What this trial is testing

The Role of Diet and Lifestyle in Breast Cancer Survival

Who this might be right for
Breast Cancer
University College London Hospitals 3,390
Very early researchLooking for participantsNCT06586047
What this trial is testing

Breast Cancer PSMA PET

Who this might be right for
Triple Negative Breast Cancer
Ahmad Shariftabrizi 30
Testing effectiveness (Phase 2)Ended earlyNCT00570258
What this trial is testing

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Who this might be right for
Metastatic Breast Cancer
University of Arkansas 27
Not applicableStudy completedNCT03273426
What this trial is testing

Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.

Who this might be right for
Breast Neoplasm
Seoul National University Hospital 40
Not applicableEnded earlyNCT01543126
What this trial is testing

IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 9
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Not applicableLooking for participantsNCT06104085
What this trial is testing

99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Ended earlyNCT03259425
What this trial is testing

Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma

Who this might be right for
Melanoma
University of Utah 7
Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Large-scale testing (Phase 3)Looking for participantsNCT05549297
What this trial is testing

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Who this might be right for
Advanced Melanoma
Immunocore Ltd 540
Testing effectiveness (Phase 2)Ended earlyNCT04924413
What this trial is testing

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Quanli Gao 9
Early research (Phase 1)Looking for participantsNCT04890613
What this trial is testing

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Who this might be right for
Advanced Solid Tumor
Senhwa Biosciences, Inc. 52
Next Page